Canada markets closed

ChemoCentryx, Inc. (CCXI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
32.43-2.04 (-5.92%)
At close: 4:00PM EDT
32.43 0.00 (0.00%)
After hours: 07:52PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close34.47
Bid32.47 x 1100
Ask32.60 x 1100
Day's Range31.72 - 34.86
52 Week Range9.53 - 70.29
Avg. Volume4,730,503
Market Cap2.267B
Beta (5Y Monthly)1.41
PE Ratio (TTM)N/A
EPS (TTM)-1.77
Earnings DateNov. 08, 2021 - Nov. 12, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est70.88
  • Motley Fool

    Is It Too Late to Buy ChemoCentryx Stock?

    The U.S. Food and Drug Administration (FDA) granted approval for the company's autoimmune drug, avacopan, which instantly led to shares of ChemoCentryx more than doubling in value. For investors who didn't want to take on the risk heading into the FDA decision, the obvious question now is whether it's too late to invest in the healthcare stock. After amassing such impressive returns over a short time frame, can investors who buy the stock today still expect to earn a good return on their investment?

  • Motley Fool

    2 Super-Charged Growth Stocks to Buy Now

    Growth stocks can be a thing of beauty. The trick, if you will, is to suss out growth stocks that won't rot on the vine, so to speak. While both of these biotech stocks have more than doubled in value in the past three years, I believe each of these healthcare equities still has a lot of room to run in 2022 and beyond.

  • Zacks

    Company News for Oct 11, 2021

    Companies in The News Are: ACCD,CCXI,ALLO,WMT